ISHWARIA MOHAN SUBBIAH

TitleAssistant Professor
InstitutionMD Anderson
DepartmentPalliative Care & Rehabilitation Medicine
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Subbiah IM, Grewal US. Development of a Regulatory Framework Governing Health Care Interactions on Social Media Platforms. JCO Oncol Pract. 2022 Mar 31; OP2100879. PMID: 35357900.
      Citations:    Fields:    
    2. Subbiah IM, Markham MJ, Graff SL, Matt-Amaral LB, Close JL, Griffith KA, Jagsi R. Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual Harassment. J Clin Oncol. 2022 04 10; 40(11):1186-1195. PMID: 35089804.
      Citations:    Fields:    Translation:Humans
    3. Subbiah IM, Tejero I, Alibhai SMH. Multidimensional impact of the geriatric assessment in the cancer care of older adults. Cancer. 2022 03 01; 128(5):953-955. PMID: 34762733.
      Citations:    Fields:    Translation:Humans
    4. Liposits G, Akagunduz B, Rodgers L, Roy M, Velasco RN, Subbiah IM, Marinho J. Highlighting selected research conducted in older patients presented at the 23rd European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer (2021): Young International Society of Geriatric Oncology Report. J Geriatr Oncol. 2022 01; 13(1):4-6. PMID: 34688559.
      Citations:    Fields:    Translation:Humans
    5. Whisenant MS, Srour SA, Williams LA, Subbiah I, Griffin D, Ponce D, Kebriaei P, Neelapu SS, Shpall E, Ahmed S, Wang XS. The Unique Symptom Burden of Patients Receiving CAR T-Cell Therapy. Semin Oncol Nurs. 2021 12; 37(6):151216. PMID: 34629213.
      Citations:    Fields:    Translation:Humans
    6. Hui D, Darke AK, Guthrie KA, Subbiah IM, Unger JM, Hershman DL, Krouse RS, Bakitas M, O'Rourke MA. Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials. JCO Oncol Pract. 2022 Apr; 18(4):e442-e451. PMID: 34606328.
      Citations: 1     Fields:    Translation:Humans
    7. Wang XS, Srour SA, Whisenant M, Subbiah IM, Chen TH, Ponce D, Gonzalez AG, Kamal M, Mendoza T, Cleland CS, Kebriaei P, Neelapu SS, Rezvani K, Ahmed S, Shpall E. Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies. Transplant Cell Ther. 2021 11; 27(11):930.e1-930.e10. PMID: 34265479.
      Citations: 2     Fields:    Translation:Humans
    8. Subbiah IM, Charone MM, Roszik J, Haider A, Vidal M, Wong A, Bruera E. Association of Edmonton Symptom Assessment System Global Distress Score With Overall Survival in Patients With Advanced Cancer. JAMA Netw Open. 2021 07 01; 4(7):e2117295. PMID: 34269810.
      Citations:    Fields:    Translation:Humans
    9. Christopherson KM, Das P, Berlind C, Lindsay WD, Ahern C, Smith BD, Subbiah IM, Koay EJ, Koong AC, Holliday EB, Ludmir EB, Minsky BD, Taniguchi CM, Smith GL. A Machine Learning Model Approach to Risk-Stratify Patients With Gastrointestinal Cancer for Hospitalization and Mortality Outcomes. Int J Radiat Oncol Biol Phys. 2021 09 01; 111(1):135-142. PMID: 33933480.
      Citations:    Fields:    Translation:Humans
    10. Ganeshan D, Kambadakone A, Nikolaidis P, Subbiah V, Subbiah IM, Devine C. Current update on gallbladder carcinoma. Abdom Radiol (NY). 2021 06; 46(6):2474-2489. PMID: 33386907.
      Citations: 4     Fields:    Translation:Humans
    11. Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, Rödel C, Fokas E, Jagsi R, Thomas CR, Subbiah IM, Taniguchi CM, Ludmir EB. Performance Status Restriction in Phase III Cancer Clinical Trials. J Natl Compr Canc Netw. 2020 10; 18(10):1322-1326. PMID: 33022640.
      Citations: 5     Fields:    Translation:Humans
    12. Kouzy R, Abi Jaoude J, Minsky BD, Das P, Koong AC, Subbiah IM, Ludmir EB, Taniguchi CM. Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades. BMJ Support Palliat Care. 2022 Mar; 12(1):42-45. PMID: 32943466.
      Citations:    Fields:    Translation:Humans
    13. Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, Thomas CR, Fogelman DR, Subbiah V, Subbiah IM, Ludmir EB. Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials. Cancers (Basel). 2020 Sep 16; 12(9). PMID: 32947844.
      Citations:    
    14. Giri S, Chakiba C, Shih YY, Chan WL, Krok-Schoen JL, Presley CJ, Williams GR, Subbiah IM. Integration of geriatric assessment into routine oncologic care and advances in geriatric oncology: A young International Society of Geriatric Oncology Report of the 2020 American Society of Clinical Oncology (ASCO) annual meeting. J Geriatr Oncol. 2020 11; 11(8):1324-1328. PMID: 32732011.
      Citations: 3     Fields:    Translation:Humans
    15. Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR, Minsky BD, Ludmir EB. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. Eur J Cancer. 2020 09; 136:176-185. PMID: 32702645.
      Citations: 3     Fields:    Translation:Humans
    16. Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR, Fuller CD, VanderWalde NA. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. J Geriatr Oncol. 2020 04; 11(3):451-454. PMID: 31711757.
      Citations: 7     Fields:    Translation:Humans
    17. Subbiah IM, Lundebjerg N, Appleby J, Wallach G, Beilenson J, Dale W. Development of a strategic plan for the dissemination and communication of aging research through the Cancer and Aging Research Group (CARG) infrastructure grant. J Geriatr Oncol. 2020 03; 11(2):359-360. PMID: 31353236.
      Citations: 3     Fields:    Translation:Humans
    18. Sheikh AR, Hsu T, Subbiah IM, Arora SP. Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. J Geriatr Oncol. 2019 11; 10(6):998-1002. PMID: 31326394.
      Citations:    Fields:    Translation:Humans
    19. Magnuson A, Li D, Hsu T, Loh KP, MacKenzie A, Presley CJ, Krok-Schoen JL, Subbiah IM, Williams GR, Wong M, Soto-Perez-de-Celis E, Sedrak MS. Mentoring pearls of wisdom: Lessons learned by mentees of Arti Hurria, MD. J Geriatr Oncol. 2020 03; 11(2):335-337. PMID: 31160209.
      Citations: 1     Fields:    Translation:Humans
    20. Subbiah IM, Hamilton E, Knoll M, Shanahan K, Meisel J. A Big World Made Small: Using Social Media to Optimize Patient Care. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:e212-e218. PMID: 31099651.
      Citations: 4     Fields:    Translation:Humans
    21. Subbiah IM. Integration of End-of-Life Care into Accountable Care Organization's Quality Measures. J Am Geriatr Soc. 2019 05; 67(5):877-878. PMID: 30969433.
      Citations:    Fields:    Translation:Humans
    22. Menta AK, Subbiah IM, Subbiah V. Bringing wearable devices into oncology practice: fitting smart technology in the clinic. Discov Med. 2018 12; 26(145):261-270. PMID: 30695675.
      Citations: 2     Fields:    Translation:Humans
    23. Subbiah IM, Tang C, Rao A, Falchook GS, Subbiah V, Tsimberidou AM, Karp D, Kurzrock R, Hong DS. Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors. Oncotarget. 2018 Jun 22; 9(48):28842-28848. PMID: 29989021.
      Citations: 3     Fields:    
    24. Sen S, Hess K, Hong DS, Naing A, Piha-Paul S, Janku F, Fu S, Subbiah IM, Liu H, Khanji R, Huang L, Moorthy S, Karp DD, Tsimberidou A, Meric-Bernstam F, Subbiah V. Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials. Br J Cancer. 2018 03 20; 118(6):763-769. PMID: 29462132.
      Citations: 6     Fields:    Translation:Humans
    25. Subbiah IM, Tsimberidou A, Subbiah V, Janku F, Roy-Chowdhuri S, Hong DS. Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape. Oncoscience. 2017 May; 4(5-6):47-56. PMID: 28781987.
      Citations: 12     
    26. Subbiah IM, Wheler JJ, Hess KR, Hong DS, Naing A, Fu S, Kurzrock R, Tsimberidou AM. Outcomes of patients =65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER. Int J Cancer. 2017 Jan 01; 140(1):208-215. PMID: 27599876.
      Citations: 3     Fields:    Translation:Humans
    27. Subbiah IM, Falchook GS, Kaseb AO, Hess KR, Tsimberidou AM, Fu S, Subbiah V, Hong DS, Naing A, Piha-Paul SA, Akmal O, Janku F, Kurzrock R. Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials. Oncotarget. 2015 Sep 29; 6(29):28453-62. PMID: 26164085.
      Citations: 4     Fields:    Translation:Humans
    28. Subbiah V, McMahon C, Patel S, Zinner R, Silva EG, Elvin JA, Subbiah IM, Ohaji C, Ganeshan DM, Anand D, Levenback CF, Berry J, Brennan T, Chmielecki J, Chalmers ZR, Mayfield J, Miller VA, Stephens PJ, Ross JS, Ali SM. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion. J Hematol Oncol. 2015 Jun 11; 8:66. PMID: 26062823.
      Citations: 29     Fields:    Translation:Humans
    29. Subbiah IM, Lei X, Weinberg JS, Sulman EP, Chavez-MacGregor M, Tripathy D, Gupta R, Varma A, Chouhan J, Guevarra RP, Valero V, Gilbert MR, Gonzalez-Angulo AM. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases. J Clin Oncol. 2015 Jul 10; 33(20):2239-45. PMID: 25987700.
      Citations: 43     Fields:    Translation:Humans
    30. Subbiah V, Berry J, Roxas M, Guha-Thakurta N, Subbiah IM, Ali SM, McMahon C, Miller V, Cascone T, Pai S, Tang Z, Heymach JV. Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases. Lung Cancer. 2015 Jul; 89(1):76-9. PMID: 25982012.
      Citations: 30     Fields:    Translation:Humans
    31. Subbiah IM, Subbiah V. Exceptional responders: in search of the science behind the miracle cancer cures. Future Oncol. 2015; 11(1):1-4. PMID: 25572778.
      Citations: 7     Fields:    Translation:Humans
    32. Subbiah IM, Blackmon SH, Correa AM, Kee B, Vaporciyan AA, Swisher SG, Eng C. Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma. Oncotarget. 2014 Aug 30; 5(16):6584-93. PMID: 25051371.
      Citations: 7     Fields:    Translation:Humans
    33. Subbiah IM, Gonzalez-Angulo AM. Advances and future directions in the targeting of HER2-positive breast cancer: implications for the future. Curr Treat Options Oncol. 2014 Mar; 15(1):41-54. PMID: 24323591.
      Citations: 8     Fields:    Translation:HumansCells
    34. Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia T, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM. Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma. Oncology. 2013; 85(4):197-203. PMID: 24051705.
      Citations: 30     Fields:    Translation:Humans
    35. Subbiah IM, Subbiah V, Tsimberidou AM, Naing A, Kaseb AO, Javle M, Fu S, Hong DS, Piha-Paul S, Wheler JJ, Hess KR, Janku F, Falchook GS, Wolff RA, Kurzrock R. Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials. Oncotarget. 2013 Jan; 4(1):156-65. PMID: 23391555.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    36. Tsimberidou AM, Leick MB, Lim J, Fu S, Wheler J, Piha-Paul SA, Hong D, Falchook GS, Naing A, Subbiah IM, Fortier A, Avritscher R, Kurzrock R. Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liver. Cancer Chemother Pharmacol. 2013 Feb; 71(2):389-97. PMID: 23143207.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    37. Tsimberidou AM, Fu S, Subbiah IM, Naing A, Hong DS, Wen S, Fortier AH, Lim J, Kurzrock R. Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis. Hepatogastroenterology. 2012 Jun; 59(116):960-4. PMID: 22580643.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    38. Subbiah IM, Lenihan DJ, Tsimberidou AM. Cardiovascular toxicity profiles of vascular-disrupting agents. Oncologist. 2011; 16(8):1120-30. PMID: 21742963.
      Citations: 28     Fields:    Translation:Humans
    39. International Journal of Cancer. 140:208-215.
    40. Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma. Oncotarget. 6:28453-28462.
    41. Comprehensive genomic profiling of clinically advanced medullary thyroid carcinoma. Oncology (Switzerland). 90:339-346.
    42. STUMP un"stumped". Journal of Hematology and Oncology. 8.
    43. Diffuse large B-cell lymphoma presenting with obstructive jaundice from a biliary stricture. Practical Gastroenterology. 35:43-48.
    SUBBIAH's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (175)
    Explore
    _
    Co-Authors (52)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _